April 15, 2013 at 14:11 PM EDT
UPDATE: Wedbush Says Sarepta Presentation at WOC Suggests Accelerated FDA Approval Coming
Traders in Sarepta Therapeutics (NASDAQ: SRPT ) shares attributed strength in the stock around 1PM EST to a positive note from Wedbush's Christopher Marai. While the stock is still negative for Monday's session, shares are now about 1.5 percent above session lows. Marai said he is "encouraged" by the company's
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here